Skip to main navigation Skip to search Skip to main content

A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled, Fixed-Dose Study Comparing the Efficacy and Safety of 2 Doses (10 and 20 mg) of Lu AA21004 in Acute Treatment of Adults With Major Depressive Disorder

Project: Research

Project Details

StatusFinished
Effective start/end date10/21/10 → 10/20/13

Funding

  • Quintiles Incorporated: $37,497.48